Evidence map›Paper›PMID 28731198›Full record

ArticleJournal of cellular physiology2018

GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.

Mehdi Amirhosseini, Rune V Madsen, K Jane Escott, Mathias P Bostrom, F Patrick Ross, Anna Fahlgren

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Epigenetic factors associated with peri-implantitis: a review.Journal of Zhejiang University. Science. B · 2025
    Review
  5. Article
  6. CombiningFrontiers in cell and developmental biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Bone Homeostasis and Gut Microbial-Dependent Signaling Pathways.Journal of microbiology and biotechnology · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. The Effects of Biomaterial Implant Wear Debris on Osteoblasts.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Mehdi AmirhosseiniDivision of Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Rune V MadsenAdult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New York.
K Jane EscottScientific Partnering & Alliances, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Melbourn, UK.
Mathias P BostromAdult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New York.
F Patrick RossAdult Reconstruction and Joint Replacement Service, Hospital for Special Surgery, New York, New York.
Anna FahlgrenDivision of Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0002-0299-1763
Hospital for Special Surgery · USLinköping University · SEAstraZeneca (United Kingdom) · GB

Funding

Enhancement of implant osseointegrationR01AR056802 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI BOSTROM, MATHIAS P. · 2010 to 2013
$1.5M
NIAMS NIH HHS R01 AR056802
6 · The paper itself

Abstract

Currently, there are no medications available to treat aseptic loosening of orthopedic implants. Using osteoprotegerin fusion protein (OPG-Fc), we previously blocked instability-induced osteoclast differentiation and peri-prosthetic osteolysis. Wnt/β-catenin signaling, which regulates OPG secretion from osteoblasts, also modulates the bone tissue response to mechanical loading. We hypothesized that activating Wnt/β-catenin signaling by inhibiting glycogen synthase kinase-3β (GSK-3β) would reduce instability-induced bone loss through regulation of both osteoblast and osteoclast differentiation. We examined effects of GSK-3β inhibition on regulation of RANKL and OPG in a rat model of mechanical instability-induced peri-implant osteolysis. The rats were treated daily with a GSK-3β inhibitor, AR28 (20 mg/kg bw), for up to 5 days. Bone tissue and blood serum were assessed by qRT-PCR, immunohistochemistry, and ELISA on days 3 and 5, and by micro-CT on day 5. After 3 days of treatment with AR28, mRNA levels of β-catenin, Runx2, Osterix, Col1α1, and ALP were increased leading to higher osteoblast numbers compared to vehicle-treated animals. BMP-2 and Wnt16 mRNA levels were downregulated by mechanical instability and this was rescued by GSK-3β inhibition. Osteoclast numbers were decreased significantly after 3 days of GSK-3β inhibition, which correlated with enhanced OPG mRNA expression. This was accompanied by decreased serum levels of TRAP5b on days 3 and 5. Treatment with AR28 upregulated osteoblast differentiation, while osteoclastogenesis was blunted, leading to increased bone mass by day 5. These data suggest that GSK-3β inactivation suppresses osteolysis through regulating both osteoblast and osteoclast differentiation in a rat model of instability-induced osteolysis.

Indexed as

Prosthesis FailureAlkaline PhosphataseAnimalsbeta CateninBone Morphogenetic Protein 2Bone PlatesCell DifferentiationCell ProliferationCollagen Type ICollagen Type I, alpha 1 ChainCore Binding Factor Alpha 1 SubunitDisease Models, AnimalGene Expression RegulationGlycogen Synthase Kinase 3 betaMaleOsteoblastsAcp5 protein, ratAlkaline Phosphatasebeta CateninBmp2 protein, ratBone Morphogenetic Protein 2Collagen Type ICollagen Type I, alpha 1 ChainCore Binding Factor Alpha 1 SubunitCtnnb1 protein, ratGlycogen Synthase Kinase 3 betaGsk3b protein, ratOsteoprotegerinProtein Kinase InhibitorsRANK LigandRNA, MessengerRunx2 protein, ratSp7 protein, ratTartrate-Resistant Acid PhosphataseTnfrsf11b protein, ratTranscription Factorsbone implantGSK-3βmechanical instabilityosteolysisWnt signaling

Identifiers

PMID28731198
PMCPMC5705568
OpenAlexW2737378411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.